Identification and Development of Novel Inhibitors of Toxoplasma gondii Enoyl Reductase

Toxoplasmosis causes significant morbidity and mortality and yet available medicines are limited by toxicities and hypersensitivity. Since improved medicines are needed urgently, rational approaches were used to identify novel lead compounds effective against Toxoplasma gondii enoyl reductase (TgENR...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tipparaju, Suresh K., Muench, Stephen P., Mui, Ernest J., Ruzheinikov, Sergey N., Lu, Jeffrey Z., Hutson, Samuel L., Kirisits, Michael J., Prigge, Sean T., Roberts, Craig W., Henriquez, Fiona L., Kozikowski, Alan P., Rice, David W., McLeod, Rima L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2932859/
https://ncbi.nlm.nih.gov/pubmed/20698542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm9017724
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados